Listed Pearl Enterprises Again Lift Industrial Heat Direct Financing Amount Of 4.6 Billion Yuan

Listed Pearl Enterprises Again Lift Industrial Heat Direct Financing Amount Of 4.6 Billion Yuan

The reporter combing the trend of Zhuhai listed enterprises in the past year found that in optimizing the allocation of resources, a number of enterprises with a keen sense of smell have taken actions, restructuring, mergers and acquisitions and a series of capital operations one after another, boosting structural upgrading and industrial iteration.

The reporter learned that, generally speaking, listed enterprises raised funds in the real field of investment expansion opportunities are still relatively limited, but more and more enterprises have been gradually increasing the investment in the real economy projects. In addition, some enterprises find a new way to support the development of the real economy by giving play to the advantages of industrial investment funds.

Nanfang Daily reporter Shen Mengyi

Investment and acquisition enterprises "go out" to strengthen the chain

Merger and reorganization is an important means of capital operation. Open the merger and acquisition map of listed pearl enterprises in this year, the destinations from overseas to domestic major regions, the fields involved are mainly high-tech industries.

The most eye-catching scene came at the end of last year, when Naxda (formerly Apex), Pacific Alliance Investment and Junilian Capital successfully acquired Lexmark International, the largest cross-border merger in the printing industry.

The acquisition has given Naxda the key to enter the high-end printer market. Zhang Jianzhou, secretary to the board of directors of the company, told reporters that at present, the integration of the relevant business lines is in an orderly way, and there will be synergies in product production, sales channels, cost control and other aspects.

In order to further integrate the industry resources, in April this year, Nastar announced that it would acquire Zhuhai Xinwei Technology Co., LTD., Zhuhai Zhongrun Jingjie Printing Technology Co., LTD., and Zhuhai Tuojia Technology Co., LTD., continuing to focus on integrated circuit (chip) business and the whole industrial chain business of printers.

More mergers and acquisitions are taking place at home.

In May, Yuanguang Software announced the acquisition of 67% of Hangzhou Haomei Technology Co., LTD., and increased capital in Hangzhou Haomei.

"The customer resources of the target company are highly matched with the company, and it has been deeply engaged in the field of distribution network production informatization for many years. Its business resources and technology accumulation are highly complementary to the strategic development direction of the company in the field of electric power production." Yuanguang Software said that the smooth implementation of the investment will further expand the company's business, improve the company's overall competitiveness and profitability, open new development space for the company in the field of distribution network information and intelligence, enhance the company's comprehensive strength, conducive to the company's long-term development.

Paulette, which focuses on the hemodialysis ecosystem, has also made remarkable moves this year. The announcement shows that the company intends to raise funds through the private offering to buy 40% of the shares of Zhi Xin Hongda and Changzhou Huayue 60% of the shares, and through its own funds to acquire Wuhan Keridi and Guangzhou Yili.

It is reported that the first three target companies are mainly engaged in the research and development, production and sales of hemodialysis-related instruments and products, while Guangzhou Yili is a professional production of water treatment equipment, all of which are highly competitive enterprises in the industry.

"The company strives to establish hemodialysis consumables and hemodialysis equipment production bases in Northeast China, North China, South China, East China and Central China through the model of extended acquisition and self-construction, so as to break regional restrictions and reduce costs." Paulette said.

As a strong rival of Paulette, deep cultivation in the field of blood purification of health sail biological is not to be outdone. In June, Jianfan Biological Company announced to pay cash for a 95% stake in Tianjin Standard Biological Preparations Co., LTD.

According to the introduction, Standard biological main dialysis powder products are mainly used in the field of uremia. "In this field, the target customer groups of the company and the target company are overlapped, and the industry synergies can be better exploited. After the completion of this acquisition, the company will be able to quickly enter the North China region, forming the industrial layout of South, central and North China."

The amount of direct financing in the first half of the year totaled 4.6 billion yuan

According to statistics from Zhuhai Financial Bureau, as of the end of June, the total amount of direct financing through equity refinancing and corporate bonds in Zhuhai totaled 4.6 billion yuan.

Take the GEM listed in the first half of the year as an example. This enterprise located in the high-tech zone needs to expand the production capacity of fiber laser devices, build a research and development center, and supplement the working capital due to its rapid growth. In March 2017, the company publicly issued 22 million new shares in the A-share market, raising a net capital of 220 million yuan to meet the capital needs, while the financing cost is almost zero.

The scientific and technological innovative enterprises represented by Guangku Technology are making full use of the direct financing function of the capital market, providing a quick transfusion of blood to the real economy and providing long-term, low-cost fund guarantee for their own innovation and development.

In September, Rezon raised 1.458 billion yuan in a private offering. According to the newly changed use of funds, among them, 450 million yuan will be used for the project of in-depth development and industrialization upgrading of eprazole series innovative products, 143 million yuan will be used for the relocation and expansion project (Phase I) of Lizon Group New Beijiang Pharmaceutical Co., LTD., and 53 million yuan will be used for the technical renovation project of bag infusion workshop of Lizon Group Limin Pharmaceutical Factory. 411 million yuan will be used for the construction project of long-lasting microsphere technology research and development platform, which will greatly improve the company's core competitiveness and anti-risk ability.

At the Zhuhai real economy meeting held at the end of last month, a number of listed companies completed project signing. With the coming of this big wave of projects, the proportion of direct financing of listed pearl enterprises is expected to increase further, and its radiation to the real economy of Zhuhai will be further enhanced.

Among them, Nastar Corporation plans to build Nastar headquarters and information technology research institute in Hong Kong District, and its parent company Sina Technology will invest in the construction of Sina printing machine Industrial Park, which will be built into an international research and development and manufacturing base of office equipment.

The two subsidiaries of Gree Electric Appliances will respectively build the electronic core device project and the mold research and development and production base of Gree Daikin. In addition, Obit plans to build Zhuhai geographic information industry incubation base, Jianfan Biological will build Jianfan hemodialyzer production base, Lihe Stock plans to invest in the construction of high-tech incubation park.

The financial sector has set up an industrial investment fund to support the development of the real economy

While actively involved in the construction of real projects, some listed companies began to actively participate in the establishment of industrial funds, centering on their own industrial chain layout, through equity investment to support the development of real economy.

In May this year, Yuanguang Software deliberated and passed relevant motions, agreeing to invest abroad and participate in the establishment of the Ediuguang blockchain industry fund. The fund, with a scale of 200 million yuan, mainly invests in blockchain-related projects.

As one of the basic protocols of the next generation of global credit authentication and value Internet, blockchain will become a strong driver of the transformation of traditional industries in the "Internet" era, and is regarded as the core technology with the greatest potential to trigger the fifth round of disruptive revolution.

Li Meiping, supervisor of Zhongguancun Blockchain Industry Alliance and senior vice president of Yuanguang Software, said that Yuanguang Software understands the power of emerging technologies, pays high attention to the value brought by blockchain technology to various industrial changes, and has organized a blockchain research team and set up a laboratory. So far, it has made certain technological breakthroughs and declared 3 blockchain invention patents. Make active efforts for the popularization and promotion of blockchain technology.

Dietary supplement leader BiHealth announced in January that its wholly-owned subsidiary, Hong Kong Bairi, has decided to invest $5 million of its own capital in brcinnovation lp (the "brc Fund") as a limited partner.

It is reported that the investment areas of brc fund include precision medicine, medical health, cloud computing, big data, enterprise applications, mobile Internet, robotics, artificial intelligence, virtual reality, augmented reality, financial technology, etc.

According to the announcement, the company will participate in the investment of brc fund, with the help of the experience and resources of professional partners, to invest in the digital health and precision medicine related technology fields in the US market, including the investment direction of medical health, deep learning based on big data. Through cooperation, we can give full play to our respective advantages to expand the investment capacity of the company, better seize the development opportunities of the big health industry, and achieve better investment returns by investing in high-quality projects with high growth potential.

Hengji Daxin, which is mainly engaged in chemical warehousing business, is also actively transforming into the big health industry.

At present, Henderson Daxin has participated in the establishment of the merger and acquisition investment fund in the big health industry through its subsidiary Heng Capital Venture Capital and its holding subsidiary Henderson Star Rui. The investment scale of the first phase of the industrial M&A Fund is 150 million yuan. It has completed the industrial and commercial registration procedures and obtained the business license, and completed the fund filing procedures in the Asset Management Association of China.

In addition, this year, Allzhi Technology also announced that it would participate in the establishment of industrial investment funds named Shenzhen Qianhai Yi Xin Investment Partnership and Shenzhen Anchuang Technology Equity Investment Partnership. The two funds will mainly invest in high-quality companies related to integrated circuits and industries related to intelligent systems and the Internet of Things, according to the announcement.